摘要
本实验采作细胞培养技术,从喉癌患者颈廓清淋巴结中提取的巨噬细胞(Mphi)作效应细胞,喉癌患者自体癌细胞及K562细胞作靶细胞,分别混合培养(两组均加PHA作为刺激原),结果表明:喉癌患者颈部肿大淋巴结Mphi对自体癌细胞(35例)及K562细胞(30例)均有杀伤能力;此外,我们还对比了未转移淋巴结(N0组,18例)与转移淋巴结(N+组,17例)MPhi杀伤能力,结果N0组高于N+组,差异非常显著(P<0.01)。结果提示,喉癌患者颈部引流淋巴结中尚存在着免疫活性细胞,并具有肮肿瘤免疫潜能,该实验为临床合理实施颈廓清术及将活化的Mphi应用于肿瘤免疫治疗提供理论依据。
Autologous laryngocarcinoma cells and K562 cells were used as targetcells to evaluate the tumoricidal activity of macrophages which were isolated from re-gional lymph nodes of laryngocarcinorna patients by the cell culture technique(at an ef-fector to target cell ratio of lO: 1). Both of the groups were added PHA as stimulator.The results indicated that macrophages had certain tumoricidal activity to both autolo-gous tumor cells (35 cases ) and K562 cells (3O cases ). The tumoricidal activities ofmacrophages were observed comparatively between non-metastatic lymph nodes (N0group )and metastatic lymph nodes (N + group). The results demonstrated that the tumo-ricidal activity of N0 group was significantly higher than that of N+ group. The resultsshowed that there were immune-active cells in the lymph nodes of the patients withlaryngocarcinoma and provided theoretical basis of using rnacrophages in anti-tumor im-munologic treatment,and they also suggested that neck desection should be done ratio-nally to the laryngocarcinoma patients.
出处
《耳鼻咽喉(头颈外科)》
1999年第6期360-362,共3页
Chinese Arch Otolaryngology-Head Neck Surg
基金
卫生部科研基金!91308268